InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 312368

Friday, 11/10/2017 8:25:39 AM

Friday, November 10, 2017 8:25:39 AM

Post# of 346487

The below conference was just in June 2017 and I was surprised to see Epiontis there ....as they discuss secondary endpoints and now imagine those secondary endpoints coming Peregrine's way......also note JUNO presence



First, we all know Epiontis and Precision for Medicine working with Peregrine Pharmaceuticals and we all now know very well about Bird&Bird legal advising Precision For Medicine to all of a sudden buy out Epiontis and there is much more if one wants to scroll back to the post this was in reply to and work your way back and forth for those postings....

For now, we know Peregrine and Epiontis and Precision For Medicine at SITC this weekend ....so now it should become more obvious how important Biomarkers are as they lead to surrogate endpoints

Where did all this begin? Well a big part of it was with The Turbachova Lab and on many patents and founder co founder with Sven ...etc would be "Ivana Turbachova" so of course it is a surprise to yet have another collaborator with Peregrine Pharmaceuticals, working in their own ways to advance science and yes...PS Targeting new ...all of a sudden show up deceased.

Why is it only being discovered on Ivana patents though? Does anyone else now find it strange that Peregrines late Dr Phil Thorpe also all of a sudden found passed away in his lab, supposedly? Is it time to make a list of others like the late Andrew Parsa as well and do we even acknowledge the possibilities ....

What happens to the patents held by Ivana Turbachova and what PS Targeting collaborations we're going on.....why did Bird&Bird advise Precision For Medicine to buy out Epiontis where Ivana was ...and maybe more puzzle pieces to come will help make some sense out of it ...



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News